Clinical Reasoning: A 6-week-old infant with migrating focal seizures

Neurology. 2020 Jan 28;94(4):178-183. doi: 10.1212/WNL.0000000000008842. Epub 2020 Jan 13.

Authors

Ittai Bushlin¹, Lacey Smith², Jurriaan M Peters², Christelle Moufawad El Achkar²

Affiliations

¹ From the Epilepsy Genetics Program (L.S., C.M.E.A.) and Clinical Neurophysiology Fellowship Program (J.M.P.), Division of Epilepsy (I.B.), Department of Neurology, Boston Children's Hospital, MA. Ittai.Bushlin@childrens.harvard.edu.
² From the Epilepsy Genetics Program (L.S., C.M.E.A.) and Clinical Neurophysiology Fellowship Program (J.M.P.), Division of Epilepsy (I.B.), Department of Neurology, Boston Children's Hospital, MA.

PMID: 31932516
DOI: 10.1212/WNL.0000000000008842

No abstract available

Publication types

Case Reports

MeSH terms

Anticonvulsants / therapeutic use
Humans
Infant
Male
Nerve Tissue Proteins / genetics*
Polymorphism, Single Nucleotide
Potassium Channels, Sodium-Activated / genetics*
Quinidine / therapeutic use
Seizures / drug therapy
Seizures / genetics*

Substances

Anticonvulsants
KCNT1 protein, human
Nerve Tissue Proteins
Potassium Channels, Sodium-Activated
Quinidine